3 Top Healthcare Stocks to Buy in April

By Newsfeedback@Fool Com (Alex Carchidi)about 1 month ago

Between scientific innovation, new business models, and a resurging global economy, there's a tremendous amount of opportunity in the healthcare sector right now. In a way, that makes the process of picking winning investments more difficult. After all, if there are thousands of options that look pretty good at the moment, it can be hard to find companies that truly look great, especially in the long term, which is what matters.

To circumvent this issue, I've picked three stocks that have positive momentum in the short term, but even larger long-term prospects. Let's investigate in more detail so that you can evaluate whether one of these might be worth an investment this month.

AD

Image source: Getty Images.

1. Invitae

Genetic testing company Invitae (NYSE:NVTA) offers an array of saliva-based kits that doctors prescribe to consumers, who then collect and mail a sample from the comfort of their homes. For everything from cardiovascular disease risk to hereditary disorders, Invitae has a solution.

With revenue growth of 29% year over year and $279.6 million in annual revenue over the course of 2020, it's clear that Invitae is a company on the up-and-up. Test kit volume is rising sharply, and it will likely surpass 250,000 tests per quarter by the end of this year. But, for investors, perhaps the largest advantage is that the company is in the process of proving that its mail-in business model is cost-effective.

Continue read on fool.com